Answers are grounded in this paper and cite their sources.
Background. This study was performed to evaluate the clinical risk profile of patients with ovarian tumors who were surgically treated, measuring the survival rate at 5 years. Method. The medical records of 237 women between ≤30 and ≥60 years old, from the surgery and obstetrics and gynecology clinics of “St. Andrew the Apostle” County Emergency Clinical Hospital, Constanţa, Romania, were analyzed, taking into account the following variables: age, parity, menarche and menopause precocity, gynecological pathology association, serum cancer antigen (CA) 125 marker, and tumor, lymph node and metastasis (TNM) staging and surgical treatment. Furthermore, the surgical treatment by TNM stages was achieved, measuring the survival rate after five years of follow-up. Results. In our study, the highest prevalence of malignant ovarian cancer was seen at ages ≥60 years old (55.69%). Most of the patients with malignant disease were multiparous (81.85%) and the menarche seemed to appear more earlier (i.e., between 10 and 12 years) in about 58.22% of patients. Moreover, from 161 menopausal patients, the higher prevalence was seen at the group between 45 and 55 years old, not being dependent on the earlier appearance. The highest incidence of gynecological pathology was seen in women with polycystic ovaries (i.e., 5.48%). Regarding serum CA125 tumoral marker, higher values were noticed in the majority of patients (89.51%). Most of the patients were diagnosed in stage III TNM (36.58%), followed by stage II (26.58%) and stage IV (20.67%). The highest prevalence of surgical treatment in the first and second stages was represented by total hysterectomy with bilateral anexectomy, omentectomy and peritoneal lavage, and for the third and fourth stages, total hysterectomy, bilateral anexectomy, omentectomy, peritonectomy and lymphadenectomy, with a better survival rate at five years seen in patients under the age of 30 years old. Conclusions. Thus, our study shows the need to create a screening for patients at risk for ovarian cancer which present higher age, multiparity, early menarche, polycystic ovaries association, and higher serum CA126 marker values. The survival rate at five years of folow-up shows a higher incidence of survival in patients under 30 years old, probably due to the earlier stages detected.
No takes yet. Share an insight, caveat, or question.
Niţu et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: